Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Medecine Sciences : M/S
|
June 15, 2017
[Innate lymphoid cells]
Adeline Crinier, Charlotte Viant, Mathilde Girard-Madoux, et al.
Cell Reports
|
August 14, 2020
Distinct Waves from the Hemogenic Endothelium Give Rise to Layered Lymphoid Tissue Inducer Cell Ontogeny
Milesa Simic, Iris Manosalva, Lionel Spinelli, et al.
Immunity
|
November 11, 2018
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier, Pierre Milpied, Bertrand Escalière, et al.
Science Immunology
|
November 15, 2024
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
Olivier Demaria, Guillaume Habif, Marie Vetizou, et al.
Cell Reports. Medicine
|
October 19, 2022
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
Olivier Demaria, Laurent Gauthier, Marie Vetizou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Medecine Sciences : M/S
|
June 15, 2017
[Innate lymphoid cells]
Adeline Crinier, Charlotte Viant, Mathilde Girard-Madoux, et al.
Cell Reports
|
August 14, 2020
Distinct Waves from the Hemogenic Endothelium Give Rise to Layered Lymphoid Tissue Inducer Cell Ontogeny
Milesa Simic, Iris Manosalva, Lionel Spinelli, et al.
Immunity
|
November 11, 2018
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier, Pierre Milpied, Bertrand Escalière, et al.
Science Immunology
|
November 15, 2024
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
Olivier Demaria, Guillaume Habif, Marie Vetizou, et al.
Cell Reports. Medicine
|
October 19, 2022
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
Olivier Demaria, Laurent Gauthier, Marie Vetizou, et al.
Page
of 1